| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $2.19 (Beat by $0.13) |
| EPS GAAP Actual | $2.19 (Beat by $0.13) |
| Revenue Actual | $1.659B |
| Revenue Surprise | Beat by $1659M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.71835 |
| EPS GAAP Estimate | $1.71835 |
| Revenue Estimate | $1.48478B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 6.65 | 13.93 | 6.02809 | 7.27539 | 2 |
| Dec 2028 | 6.49 | 14.27 | 5.88305 | 7.10034 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.19 | 0.31297 | 1.659B | 17.42% | 31.45M |
| FQ2 2025 (Jun 2025) | 2.3696 | 0.51764 | 1.89B | 16.83% | 293.85M |
| FQ1 2025 (Mar 2025) | 1.85 | 1.85 | 1.663B | 11.61% | 1663M |
| FQ4 2024 (Dec 2024) | 1.89 | 1.89 | 1.524B | -3.08% | 1524M |
| FQ3 2024 (Sep 2024) | 1.55 | 1.55 | 1.37B | 7.08% | 1370M |
| FQ2 2024 (Jun 2024) | 2.3 | 2.3 | 1.572B | -12.91% | 1572M |
| FQ1 2024 (Mar 2024) | 1.03 | 1.03 | 1.47B | -36.87% | 1470M |
| FQ4 2023 (Dec 2023) | 1.44 | 1.44 | 1.571B | 100% | 1571M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.71835
Consensus Revenue Estimates
1.48478B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.5479 | -- | 1.41503 | 1.64502 | 1 |
| FQ3 2027 (Sep 2027) | 0.40876 | -- | 0.38102 | 0.43062 | 2 |
| FQ2 2027 (Jun 2027) | 1.38192 | -- | 1.28815 | 1.45583 | 2 |
| FQ1 2027 (Mar 2027) | 1.88311 | -- | 1.75533 | 1.98383 | 2 |
| FQ4 2026 (Oct 2026) | 0.23399 | -- | 0.20438 | 0.26096 | 3 |
| FQ3 2026 (Jul 2026) | 1.32539 | -65.23 | 1.15766 | 1.47815 | 4 |
| FQ2 2026 (Jun 2026) | 1.25633 | -88.61 | 1.16001 | 1.36541 | 5 |
| FQ1 2026 (Mar 2026) | 1.71835 | -7.66 | 1.5866 | 1.86755 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.68B | -- | 1.57B | 1.76B | 2 |
| FQ3 2027 (Sep 2027) | 1.29B | -- | 1.22B | 1.34B | 2 |
| FQ2 2027 (Jun 2027) | 1.49B | -- | 1.42B | 1.55B | 2 |
| FQ1 2027 (Mar 2027) | 1.54B | -- | 1.46B | 1.61B | 2 |
| FQ4 2026 (Oct 2026) | 1.18B | -- | 1.06B | 1.28B | 4 |
| FQ3 2026 (Jul 2026) | 1.56B | -6.44 | 1.41B | 1.7B | 5 |
| FQ2 2026 (Jun 2026) | 1.52B | -24.68 | 1.43B | 1.62B | 5 |
| FQ1 2026 (Mar 2026) | 1.48B | -12 | 1.4B | 1.58B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.87703 | 2.19 | 0.31297 | 14.29% |
| FQ2 2025 (Jun 2025) | 1.85196 | 2.3696 | 0.51764 | 21.85% |
| FQ1 2025 (Mar 2025) | 1.85 | 1.85 | 100% | |
| FQ4 2024 (Dec 2024) | 1.89 | 1.89 | 100% | |
| FQ3 2024 (Sep 2024) | 1.55 | 1.55 | 100% | |
| FQ2 2024 (Jun 2024) | 2.3 | 2.3 | 100% | |
| FQ1 2024 (Mar 2024) | 1.03 | 1.03 | 100% | |
| FQ4 2023 (Dec 2023) | 1.44 | 1.44 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.63B | $1.66B | $31.45M | 1.9% |
| FQ2 2025 (Jun 2025) | $1.6B | $1.89B | $293.85M | 15.55% |
| FQ1 2025 (Mar 2025) | $0B | $1.66B | $1663M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.52B | $1524M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.37B | $1370M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.57B | $1572M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.47B | $1470M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.57B | $1571M | 100% |